SOPHiA GENETICS SA Long-Term Investments 2020-2024 | SOPH
SOPHiA GENETICS SA long-term investments from 2020 to 2024. Long-term investments can be defined as the aggregate value of debt and or equity investments with maturities or benefits lasting more than one year.
| SOPHiA GENETICS SA Annual Long-Term Investments (Millions of US $) |
|
|---|---|
| 2023 | $ |
| 2022 | $ |
| 2021 | $ |
| 2020 | $ |
| 2019 | $ |
| SOPHiA GENETICS SA Quarterly Long-Term Investments (Millions of US $) |
|
|---|---|
| 2024-09-30 | |
| 2024-06-30 | |
| 2024-03-31 | |
| 2023-12-31 | |
| 2023-09-30 | |
| 2023-06-30 | |
| 2023-03-31 | |
| 2022-12-31 | |
| 2022-09-30 | |
| 2022-06-30 | |
| 2022-03-31 | |
| 2021-12-31 | |
| 2021-09-30 | |
| 2021-06-30 | |
| 2021-03-31 | |
| 2020-12-31 | |
| 2020-09-30 | |
| 2020-06-30 | |
| 2020-03-31 | |
| 2019-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.235B | $0.062B |
| SOPHiA GENETICS SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM(TM) Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. SOPHiA GENETICS SA is based in BOSTON. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $37.714B | 55.57 |
| Tempus AI (TEM) | United States | $7.994B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $6.961B | 177.00 |
| Inspire Medical Systems (INSP) | United States | $5.693B | 177.56 |
| IRhythm Technologies (IRTC) | United States | $3.453B | 0.00 |
| Privia Health (PRVA) | United States | $2.701B | 225.10 |
| Enovis (ENOV) | United States | $2.693B | 17.94 |
| Azenta (AZTA) | United States | $2.440B | 130.24 |
| Clover Health Investments (CLOV) | United States | $2.230B | 0.00 |
| Omnicell (OMCL) | United States | $2.070B | 67.71 |
| Schrodinger (SDGR) | United States | $1.819B | 0.00 |
| 10x Genomics (TXG) | United States | $1.796B | 0.00 |
| Phreesia (PHR) | United States | $1.669B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.748B | 0.00 |
| Standard BioTools (LAB) | United States | $0.588B | 0.00 |
| Talkspace (TALK) | United States | $0.537B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.515B | 0.00 |
| TruBridge (TBRG) | United States | $0.362B | 105.43 |
| Nyxoah SA (NYXH) | Belgium | $0.354B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.343B | 0.00 |
| Pulmonx (LUNG) | United States | $0.230B | 0.00 |
| American Well (AMWL) | United States | $0.169B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.096B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.069B | 0.00 |
| CareCloud (CCLD) | United States | $0.058B | 0.00 |
| HeartBeam (BEAT) | United States | $0.058B | 0.00 |
| 111 (YI) | China | $0.047B | 0.00 |
| Outset Medical (OM) | United States | $0.044B | 0.00 |
| Zepp Health (ZEPP) | China | $0.042B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.042B | 0.00 |
| Zhongchao (ZCMD) | China | $0.035B | 0.00 |
| Movano (MOVE) | United States | $0.034B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.020B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.018B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.014B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.012B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.012B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Syra Health (SYRA) | United States | $0.005B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |